Assembly Biosciences, Inc. (ASMB)

NASDAQ: ASMB · IEX Real-Time Price · USD

13.35

+0.11 (0.83%)

At close: Jul 2, 2024, 4:30 PM

12.88

-0.47 (-3.52%)

Pre-market: Jul 3, 2024, 4:00 AM EDT

Assembly Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2008
Net Income	-61.23	-93.09	-129.86	-62.15	-97.63	Upgrade
Depreciation & Amortization	0.45	0.5	0.47	0.69	0.49	Upgrade
Share-Based Compensation	5.12	6.59	5.24	21.85	20.56	Upgrade
Other Operating Activities	78.4	1.54	30.76	-23.35	-7.49	Upgrade
Operating Cash Flow	22.74	-84.46	-93.4	-62.96	-84.07	Upgrade
Capital Expenditures	-0.23	-0.1	-2.24	-0.47	-1.55	Upgrade
Acquisitions	0	1.5	1.5	-1.75	0	Upgrade
Change in Investments	-68.91	89.24	27.25	70.29	-48.76	Upgrade
Investing Cash Flow	-69.14	90.64	26.52	68.07	-50.32	Upgrade
Share Issuance / Repurchase	13.82	0.61	53.06	7.6	139.65	Upgrade
Financing Cash Flow	13.82	0.61	53.06	7.6	139.65	Upgrade
Net Cash Flow	-32.58	6.79	-13.82	12.71	5.26	Upgrade
Free Cash Flow	22.51	-84.57	-95.64	-63.43	-85.62	Upgrade
Free Cash Flow Margin	-	-	-1529.18%	-80.18%	-536.37%	Upgrade
Free Cash Flow Per Share	4.92	-20.96	-26.52	-21.48	-39.13	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).